capromab pendetide (Prostascint) Report issue

Active Ingredient History

NOW
  • Now
Indium (111In) capromab pendetide is used to image the extent of prostate cancer. Capromab is a mouse monoclonal antibody which recognizes a protein found on both prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111. Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).   Wikipedia

  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No
(111in)-capromab pendetide | 111in-capromab pendetide | 7e11-c5.3 | capromab pendetide | cc49 antibody | cyt-351 | cyt 356 | cyt-356 | cytogen 356 | (iii)in-cyt-356 | indium 111 capromab pendetide | indium-111-cyt-356 | indium (111in) capromab pendetide | indium in 111 capromab pendetide | prostascinct | prostascint

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue